SCHEMBL723509

SCHEMBL723509

CCCCCCCCCCCCCCC(=O)OC(CO)CO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 1.00
MAPK1 P28482 3/20 1.00
PRKCA P17252 5/20 0.77
PRKCE Q02156 2/20 0.77
PRKCQ Q04759 2/20 0.77
PRKCD Q05655 2/20 0.77
LMNA P02545 4/20 0.68
ALDH1A1 P00352 2/20 0.68
FAAH O00519 1/20 0.66
HPGD P15428 1/20 0.66
CNR1 P21554 1/20 0.66
CNR2 P34972 1/20 0.66
CYP1A2 P05177 2/20 0.57
MEN1 O00255 1/20 0.57
GMNN O75496 1/20 0.57
HSP90AA1 P07900 1/20 0.57
BLM P54132 1/20 0.57
KMT2A Q03164 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
NR1H4 Q96RI1 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL49586 1.00 MAPT (1.00) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL380745 1.00 MAPT (1.00) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL2934617 1.00 MAPT (1.00) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL2512364 1.00 MAPT (1.00) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL239865 1.00 MAPT (1.00) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL2507783 1.00 MAPT (1.00) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL4156197 1.00 MAPT (1.00) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL2508639 1.00 MAPT (1.00) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL2508007 1.00 MAPT (1.00) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL5276451 1.00 MAPT (1.00) MAPTMAPK1PRKCAPRKCEPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114414694-B Molecular marker related to azoospermia, and detection method and application thereof 苏州南医大创新中心 2023-04-28 CN claimed
EP-4051239-A1 POLOXAMER COMPOSITIONS WITH REDUCED SOL-GEL TRANSITION TEMPERATURES AND METHODS OF REDUCING THE SOL-GEL TRANSITION TEMPERATURE OF POLOXAMER COMPOSITIONS Rochal Technologies LLC (US) 2022-09-07 EP claimed
CN-114929200-A Method for lowering sol-gel transition temperature 罗查尔科技有限责任公司 2022-08-19 CN claimed
CN-114414694-A Molecular marker related to azoospermia and detection method and application thereof 苏州南医大创新中心 2022-04-29 CN claimed
WO-2021086698-A1 METHODS FOR REDUCING THE TEMPERATURE OF SOL-GEL TRANSITIONS ROCHAL INDUSTRIES, LLC (US) 2021-05-06 WO claimed
US-20210121575-A1 Poloxamer Compositions With Reduced Sol-Gel Transition Temperatures and Methods of Reducing the Sol-Gel Transition Temperature of Poloxamer Compositions ROCHAL INDUSTRIES, LLC (US) 2021-04-29 US claimed
JP-61015815-A None JP disclosed
EP-4451879-A1 METHODS FOR ISOLATING ANTIMICROBIAL MICROORGANISMS FROM AGRICULTURAL PRODUCTS AND USES THEREOF Apeel Technology, Inc. (US) 2024-10-30 EP disclosed
US-12090205-B2 Poloxamer compositions with reduced sol-gel transition temperatures and methods of reducing the sol-gel transition temperature of poloxamer compositions ROCHAL TECHNOLOGIES LLC (US) 2024-09-17 US disclosed
CN-118368982-A Method for separating antimicrobial microorganisms from agricultural products and use thereof 阿比尔技术公司 2024-07-19 CN disclosed
US-11929171-B2 Methods for evaluation and treatment of glycemic dysregulation and atherosclerotic cardiovascular disease and applications thereof THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2024-03-12 US disclosed
US-20230200405-A1 METHODS FOR ISOLATING ANTIMICROBIAL MICROORGANISMS FROM AGRICULTURAL PRODUCTS AND USES THEREOF APEEL TECHNOLOGY, INC. 2023-06-29 US disclosed
WO-2023122793-A1 METHODS FOR ISOLATING ANTIMICROBIAL MICROORGANISMS FROM AGRICULTURAL PRODUCTS AND USES THEREOF APEEL TECHNOLOGY, INC. (US) 2023-06-29 WO disclosed
US-20070116657-A1 Hair growth promotor composition LION CORPORATION (JP) 2007-05-24 US disclosed
EP-1671616-A1 HAIR TONIC COMPOSITION Lion Corporation (JP) 2006-06-21 EP disclosed
US-5248674-A Aids treatment NELSON-SUMISHO CO., LTD. (JP) 1993-09-28 US disclosed
EP-0397211-B1 PERCUTANEOUS ADMINISTRATION OF 3'-AZIDE-3'-DEOXYTHYMIDINE NELSON-SUMISHO Co., Ltd. (JP) 1993-05-12 EP disclosed
EP-0407959-A2 Process for producing polyol fatty acid monoesters LION CORPORATION (JP) 1991-01-16 EP disclosed
EP-0397211-A2 Percutaneous administration of 3'-azide-3'-deoxythymidine NELSON-SUMISHO Co., Ltd. (JP) 1990-11-14 EP disclosed
JP-S6115815-A COSMETIC FOR HAIR LION CORP 1986-01-23 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070116657-A1 Hair growth promotor composition BCOR, SPOUT1, IL36G MAPT 1390/4885MAPK1 1245/4885PRKCA 3961/4885
US-12090205-B2 Poloxamer compositions with reduced sol-gel transition temperatures and methods of reducing the sol-gel transition temperature of poloxamer compositions PAOX, HPGDS, SPTSSB MAPT 2244/4885MAPK1 3911/4885PRKCA 3265/4885
US-20210121575-A1 Poloxamer Compositions With Reduced Sol-Gel Transition Temperatures and Methods of Reducing the Sol-Gel Transition Temperature of Poloxamer Compositions PAOX, HPGDS, SPTSSB MAPT 2244/4885MAPK1 3911/4885PRKCA 3265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.